CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 24,172	$ 25,237
General and administrative	12,392	7,525
Total operating expenses	36,564	32,762
Loss from operations	(36,564)	(32,762)
Other income, net:
Interest income	4,376	3,246
Other income (expense), net	205	(2)
Total other income, net	4,581	3,244
Net loss	(31,983)	(29,518)
Other comprehensive loss:
Net unrealized loss on investments	(22)	(135)
Comprehensive loss	$ (32,005)	$ (29,653)
Net loss per share, basic	$ (0.43)	$ (0.58)
Net loss per share, diluted	$ (0.43)	$ (0.58)
Weighted average shares used to compute net loss per share, basic	73,916,477	50,682,469
Weighted average shares used to compute net loss per share, diluted	73,916,477	50,682,469